A long‐term, multicenter, open‐label study of risperidone in elderly patients with psychosis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International Journal of Geriatric Psychiatry

• Publication date

  2000-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/1099-1166(200006)15:6<506::AID-GPS146>3.0.CO;2-VPMID 10861916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonparametric Statistics for the Behavioral Sciences

  2022cited by this paper
• Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

  1999cited by this paper
• Risperidone in the treatment of elderly patients with psychotic disorders.

  1999cited by this paper
• Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients

  1999influential reference
• Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings.

  1998cited by this paper
• A Two‐Year Follow‐Up of Geriatric Consults in the Emergency Department

  1998cited by this paper
• Psychotropic drugs and the aging patient.

  1998cited by this paper
• Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

  1998cited by this paper
• Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

  1997cited by this paper
• The Effect of Risperidone on Cognition in Patients with Schizophrenia

  1996cited by this paper
• Outcome of Risperidone Therapy in Elderly Patients with Chronic Psychosis

  1996cited by this paper
• Goodman and Gilman 's: The pharmacological basis of therapeutics

  1996cited by this paper
• Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

  1996cited by this paper
• Risperidone in Elderly Schizophrenic Patients: An Open-Label Trial.

  1996cited by this paper
• Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

  1996cited by this paper
• The Effect of Risperidone on Cognition in Patients with Schizophrenia

  1996cited by this paper
• Newer antipsychotics and antidepressants for elderly people

  1996cited by this paper
• Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series.

  1995cited by this paper
• Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

  1995influential reference
• Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

  1995cited by this paper
• Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol

  1995cited by this paper
• Antipsychotic drug use in older adults.

  1994cited by this paper
• Risperidone in the treatment of schizophrenia.

  1994cited by this paper
• A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

  1993cited by this paper
• Principles of therapeutics.

  1992cited by this paper
• Positive and Negative Syndromes in Schizophrenia: Assessment and Research

  1992cited by this paper
• Pyramidical model of schizophrenia.

  1990cited by this paper
• Management of the behavioral symptoms associated with dementia.

  1989cited by this paper
• Care of the aging patient.

  1989cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987influential reference
• Research diagnoses for tardive dyskinesia.

  1982cited by this paper
• Burned-out schizophrenia: evidence for age effects on schizophrenic symptomatology.

  1978cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Psychopharmacologic treatment

  2020cites this paper
• Treatment of Schizophrenia and Psychoses in Older Adults: Psychopharmacological Approaches

  2019cites this paper
• Tardive dyskinesia: Risk factors, prevention, and treatment

  2019cites this paper
• Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

  2018cites this paper
• Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia.

  2017cites this paper
• Comparing the risk of tardive dyskinesia in older adults with first‐generation and second‐generation antipsychotics: a systematic review and meta‐analysis

  2016influential citation
• Current Concepts in the Diagnosis and Treatment of Schizophrenia in Later Life

  2015cites this paper
• Incidence of Tardive Dyskinesia in Older Adult Patients Treated With Olanzapine or Conventional Antipsychotics

  2015cites this paper
• Amisulpride for Older Patients With Long-Standing Schizophrenia

  2014cites this paper
• Best Practice for Antipsychotic Medication Management in Community Dwelling Older Adults with Schizophrenia

  2014cites this paper
• Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases

  2014cites this paper
• Atypical Antipsychotic-Induced Metabolic Disturbances in the Elderly

  2014cites this paper
• Use of atypical antipsychotics in the elderly: a clinical review

  2014cites this paper
• Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia

  2014cites this paper
• First-Episode Schizophrenia

  2012cites this paper
• Antipsychotic drug treatment for elderly people with late-onset schizophrenia.

  2012cites this paper
• Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms.

  2011cites this paper
• New wine in old bottle: late-life psychosis.

  2011cites this paper
• Use of paliperidone in elderly patients with schizophrenia and schizoaffective disorder: a prospective open-label short-term pilot study.

  2011cites this paper
• The tardive syndromes

  2011cites this paper
• Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia

  2011influential citation
• Elderly patients with schizophrenia and depression: diagnosis and treatment.

  2011cites this paper
• Incidence of Tardive Dyskinesia with Risperidone or Olanzapine in the Elderly: Results from a 2-Year, Prospective Study in Antipsychotic-Naïve Patients

  2011cites this paper
• Management of Schizophrenia in Late Life with Antipsychotic Medications

  2011cites this paper
• Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report

  2010cites this paper
• Sex-specific differences in side effects of psychotropic drugs: genes or gender?

  2009cites this paper
• A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients

  2009cites this paper
• Co-Occurring Depressive Symptoms in the Older Patient with Schizophrenia

  2008cites this paper
• Using risperidone for Alzheimer's dementia-associated psychosis

  2008cites this paper
• CLINICAL PRACTICE GUIDELINES ON PSYCHOSES IN ELDERLY

  2008cites this paper
• Using risperidone for Alzheimer's dementia-associated psychosis.

  2008cites this paper
• Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders

  2007cites this paper
• Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic

  2007cites this paper
• Clinical Pharmacology and Medication-Associated Side Effects: A Review of Second-Generation Antipsychotics for Schizophrenia

  2007cites this paper
• Tardive dyskinesia in geriatric patients

  2006cites this paper
• A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration

  2006cites this paper
• Clinical Manual of Geriatric Psychiatry

  2006cites this paper
• Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcome.

  2006cites this paper
• Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychotics.

  2006cites this paper
• Adverse Effects of Atypical Antipsychotics in the Elderly

  2006cites this paper
• The role of atypical antipsychotic agents in the treatment of schizophrenia and schizoaffective disorders in the elderly.

  2006cites this paper
• Antipsychotic medication for elderly people with schizophrenia.

  2006cites this paper
• Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia

  2006cites this paper
• Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh ?

  2005cites this paper
• Evidence-based review of pharmacologic and nonpharmacologic treatments for older adults with schizophrenia.

  2005cites this paper
• Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.

  2005cites this paper
• Managing Bipolar Disorder in the Elderly

  2005cites this paper
• Older people with chronic schizophrenia

  2005cites this paper
• Tardive Dyskinesia in the Era of Typical and Atypical Antipsychotics. Part 2: Incidence and Management Strategies in Patients with Schizophrenia

  2005cites this paper
• Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study

  2005cites this paper
• Antipsychotic Medications and Drug‐Induced Movement Disorders Other Than Parkinsonism: A Population‐Based Cohort Study in Older Adults

  2005cites this paper
• An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.

  2005cites this paper
• The expert consensus guideline series. Treatment of behavioral emergencies 2005.

  2005cites this paper
• Atypical Antipsychotics in Elderly Patients with Dementia or Schizophrenia: Review of Recent Literature

  2005cites this paper
• Introduction: Methods, Commentary, and Summary

  2005cites this paper
• Delusional Parasitosis Successfully Controlled with Risperidone – Two Case Reports

  2004influential citation
• A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone

  2004cites this paper
• Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).

  2004cites this paper
• Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.

  2004cites this paper
• Pain and Palliative Care in Late-Stage Dementia Patients

  2004cites this paper
• Using antipsychotic agents in older patients.

  2004cites this paper
• Efficacy and safety of long‐acting risperidone in elderly patients with schizophrenia and schizoaffective disorder

  2004cites this paper
• Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.

  2004cites this paper
• Disability Reduction in Elderly Patients with Schizophrenia

  2004cites this paper
• Délires non schizophréniques du sujet âgé

  2004cites this paper
• Schizophrenia in Late Life: Aging Effects on Symptoms and Course of Illness

  2004cites this paper
• Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

  2004cites this paper
• Conventional and Atypical Antipsychotics in the Elderly

  2003cites this paper
• Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice.

  2003cites this paper
• Conventional and atypical antipsychotics in the elderly : a review.

  2003cites this paper
• Alzheimer's Disease: Current Pharmacotherapy in the Context of Patient and Family Needs

  2003cites this paper
• Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder

  2003influential citation
• Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.

  2003cites this paper
• The impact upon extra‐pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia

  2003influential citation
• Expert opinion

  2003cites this paper
• Antipsychotic prescribing in older people.

  2003cites this paper
• Antipsychotic drug treatment for elderly people with late-onset schizophrenia.

  2003cites this paper
• [Delirious states in elderly persons. Therapeutic modalities].

  2003cites this paper
• Pharmacologic Management of Psychosis in the Elderly: A Critical Review

  2003cites this paper
• Tardive dyskinesia in elderly patients: an update.

  2003cites this paper
• No weight gain among elderly schizophrenia patients after 1 year of risperidone treatment.

  2002cites this paper
• Antipsychotic treatment for late-life schizophrenia

  2002cites this paper
• Risperidone in the treatment of psychoses in the elderly: a case report series

  2002cites this paper
• Evidence-based practices in geriatric mental health care.

  2002cites this paper
• Tardive dyskinesia in elderly patients: an update.

  2002cites this paper
• A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders.

  2002cites this paper
• ATYPICAL ANTIPSYCHOTICS: EXPERIENCE AND USE IN THE ELDERLY

  2002cites this paper
• Tratamento dos transtornos do comportamento de pacientes com demência

  2002cites this paper
• End-of-life care of persons with dementia.

  2002cites this paper
• Risperidona en el tratamiento de las psicosis en el anciano: una serie de informes clínicos

  2002cites this paper
• Treatment of the special patient with schizophrenia

  2001cites this paper
• Risperidone and tardive dyskinesia

  2001cites this paper
• Tardive dyskinesias in the elderly

  2001cites this paper
• Behavioural symptoms in Alzheimer's disease: validity of targets and present treatments.

  2001cites this paper
• Broad therapeutic uses of atypical antipsychotic medications.

  2001cites this paper
• Atypical antipsychotics in the elderly

  2001cites this paper
• Risperidone for Elderly Patients With Schizophrenia or Schizoaffective Disorder

  2000cites this paper
• Review: tardive dyskinesia is a risk factor for mortality in psychiatric patients

  2000cites this paper
• Current awareness in human psychopharmacology

  year unknowncites this paper